Literature DB >> 11299240

Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus.

A Bouayad1, H Kajino, N Waleh, J C Fouron, G Andelfinger, D R Varma, A Skoll, A Vazquez, F Gobeil, R I Clyman, S Chemtob.   

Abstract

Although the role of PGE2 in maintaining ductus arteriosus (DA) patency is well established, the specific PGE2 receptor subtype(s) (EP) involved have not been clearly identified. We used late gestation fetal and neonatal lambs to study developmental regulation of EP receptors. In the fetal DA, radioligand binding and RT-PCR assays virtually failed to detect EP1 but detected EP2, EP3D, and EP4 receptors in equivalent proportions. In the newborn lamb, DA total density was one-third of that found in the fetus and only EP2 was detected. Stimulation of EP2 and EP4 increased cAMP formation and was associated with DA relaxation. Though stimulation of EP3 inhibited cAMP formation, it surprisingly relaxed the fetal DA both in vitro and in vivo. This EP3-induced relaxation was specifically diminished by the ATP-sensitive K(+) (K(ATP)) channel blocker glibenclamide. In conclusion, PGE2 dilates the late gestation fetal DA through pathways that involve either cAMP (EP2 and EP4) or K(ATP) channels (EP3). The loss of EP3 and EP4 receptors in the newborn DA is consistent with its decreased responsiveness to PGE2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299240     DOI: 10.1152/ajpheart.2001.280.5.H2342

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

1.  Usefulness of indomethacin for patent ductus arteriosus in full-term infants.

Authors:  Takeshi Takami; Hitoshi Yoda; Tadashi Kawakami; Hideshi Yamamura; Toshio Nakanishi; Makoto Nakazawa; Yukito Takei; Tasuku Miyajima; Akinori Hoshika
Journal:  Pediatr Cardiol       Date:  2007-01-02       Impact factor: 1.655

2.  Attenuation of ductus arteriosus intimal thickening in preterm sheep twins compared with singletons.

Authors:  Satoko Ito; Utako Yokoyama; Junichi Saito; Shinichi Sato; Haruo Usuda; Shimpei Watanabe; Ryuta Kitanishi; Yuichiro Miura; Masatoshi Saito; Takushi Hanita; Tadashi Matsuda; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2017-08-23       Impact factor: 2.781

3.  Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.

Authors:  Nahid Waleh; Ryan Hodnick; Nami Jhaveri; Suzanne McConaghy; John Dagle; Steven Seidner; Donald McCurnin; Jeffrey C Murray; Robin Ohls; Ronald I Clyman
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

Review 4.  Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus.

Authors:  Mehmet Yekta Oncel; Omer Erdeve
Journal:  World J Clin Pediatr       Date:  2016-02-08

5.  Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons.

Authors:  Nahid Waleh; Donald C McCurnin; Bradley A Yoder; Philip W Shaul; Ronald I Clyman
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

Review 6.  Transcriptional profiling of the ductus arteriosus: Comparison of rodent microarrays and human RNA sequencing.

Authors:  Michael T Yarboro; Matthew D Durbin; Jennifer L Herington; Elaine L Shelton; Tao Zhang; Cris G Ebby; Jason Z Stoller; Ronald I Clyman; Jeff Reese
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

Review 7.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

Review 8.  Patent ductus arteriosus in preterm infant: Basic pathology and when to treat.

Authors:  Abdulrahman M H Al Nemri
Journal:  Sudan J Paediatr       Date:  2014

9.  Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arteriosus contractile pathways and prevents postnatal closure.

Authors:  Jeff Reese; Nahid Waleh; Stanley D Poole; Naoko Brown; Christine Roman; Ronald I Clyman
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

10.  Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase.

Authors:  B Baragatti; F Brizzi; C Ackerley; S Barogi; L R Ballou; F Coceani
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.